Our cardiorespiratory health research focuses on understanding the relationship between infectious diseases and cardiovascular and respiratory outcomes, including acute and long-term complications, healthcare utilization and high-risk populations.
cardiovascular & Infectious Disease
Cardiorespiratory Health
Cardiorespiratory health research is important because infectious diseases can contribute to serious heart and lung complications, creating a need for real-world evidence to guide prevention, clinical care, and public health strategies.
Key Publications
- Bourdeau M, Vadlamudi NK, Bastien N, Embree J, Halperin SA, Jadavji T, Kazmi K, Langley JM, Lebel MH, Le Saux N, Moore D, Morris SK, Pernica JM, Robinson J, Sadarangani M, Bettinger JA, Papenburg J; Canadian Immunization Monitoring Program Active (IMPACT) Investigators. Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic. JAMA Netw Open. 2023 Oct 2;6(10):e2336863. doi: 10.1001/jamanetworkopen.2023.36863. PMID: 37792376; PMCID: PMC10551765.
- Marra F, Zhang A, Gillman E, Bessai K, Parhar K, Vadlamudi NK. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis. Int J Infect Dis. 2020 Oct;99:204-213. doi: 10.1016/j.ijid.2020.07.038. Epub 2020 Jul 29. PMID: 32735953.
- Yang J, Smith SM, Jiao T, Smith K, Shirley DA, Veena V, Iovine NM, Vadlamudi NK. P-672. Comparative Risk of Major Adverse Cardiovascular Events Following RSV versus Influenza Hospitalization in the United States: A MarketScan Database Retrospective Cohort Study. Open Forum Infect Dis. 2026 Jan 11;13(Suppl 1):ofaf695.885. doi: 10.1093/ofid/ofaf695.885. PMCID: PMC12792668.